{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T18:09:00Z","timestamp":1790014140513,"version":"4.0.1"},"reference-count":91,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,4,24]],"date-time":"2025-04-24T00:00:00Z","timestamp":1745452800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Nutr."],"abstract":"<jats:p>Hereditary ataxia (HA) is a diverse group of rare inherited neurological disorders characterised by cerebellar impairment and the progressive degeneration of spinocerebellar tracts and the spinal cord. These conditions manifest predominantly as unsteady gait, speech difficulties, dysphagia and motor skill impairment. The complex genetic causes and varied disease mechanisms underlying HA contribute to the multi-systemic symptoms which pose challenges in developing targeted effective treatments. Currently, available options for HA primarily focus on symptomatic management, highlighting a critical need for complementary therapeutic strategies, such as dietary and lifestyle interventions. This review explains recent findings on dietary and nutraceutical interventions, as well as lifestyle modifications such as exercise and rehabilitation programs for HA. It outlines common types of HA, including Friedreich ataxia, spinocerebellar ataxias, ataxia with vitamin E deficiency, ataxia-telangiectasia, and studies on a mixed cohort of patients with HA. The current management options, therapeutic implications of findings from pre-clinical and clinical data and future directions to advance the treatment of HA will also be discussed. The integration of nutraceuticals and rehabilitation programs with current methods of symptomatic management is encouraged for the holistic treatment of HA. These interventions will complement the use of various technological aids with the support of a multidisciplinary health and medical team to improve monitoring of the health status and disease progression of affected individuals; thus facilitating early treatment and an optimised clinical outcome.<\/jats:p>","DOI":"10.3389\/fnut.2025.1548821","type":"journal-article","created":{"date-parts":[[2025,4,24]],"date-time":"2025-04-24T05:30:59Z","timestamp":1745472659000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Dietary and lifestyle interventions for the management of hereditary ataxias"],"prefix":"10.3389","volume":"12","author":[{"given":"Wenyao","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faith A. A.","family":"Kwa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,4,24]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1038\/gim.2013.28","article-title":"Hereditary ataxias: overview","volume":"15","author":"Jayadev","year":"2013","journal-title":"Genet Med"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1038\/s41582-018-0051-6","article-title":"Spinocerebellar ataxias: prospects and challenges for therapy development","volume":"14","author":"Ashizawa","year":"2018","journal-title":"Nat Rev Neurol"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"319","DOI":"10.3390\/cells13040319","article-title":"Hereditary ataxias: from bench to clinic, where do we stand?","volume":"13","author":"Pilotto","year":"2024","journal-title":"Cells"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.molmed.2023.12.002","article-title":"Omaveloxolone: a groundbreaking milestone as the first FDA-approved drug for Friedreich ataxia","volume":"30","author":"Pilotto","year":"2024","journal-title":"Trends Mol Med"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"e6303","DOI":"10.1002\/ccr3.6303","article-title":"Ataxia due to vitamin E deficiency: a case report and updated review","volume":"10","author":"Thapa","year":"2022","journal-title":"Clin Case Reports"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"7665","DOI":"10.1038\/s41467-024-52148-1","article-title":"Identification and characterisation of pathogenic and non-pathogenic FGF14 repeat expansions","volume":"15","author":"Mohren","year":"2024","journal-title":"Nat Commun"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"472","DOI":"10.3389\/fneur.2017.00472","article-title":"Spinocerebellar Ataxia type 2: Clinicogenetic aspects, mechanistic insights, and management approaches","volume":"8","author":"Velazquez-Perez","year":"2017","journal-title":"Front Neurol"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s10048-023-00741-9","article-title":"Atypical retinopathy in ataxia with vitamin E deficiency: report of a sibship","volume":"25","author":"Abramowicz","year":"2024","journal-title":"Neurogenetics"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.neurol.2024.03.005","article-title":"Identification and characterization of repeat expansions in neurological disorders: methodologies, tools, and strategies","volume":"180","author":"Leitao","year":"2024","journal-title":"Rev Neurol (Paris)"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"264","DOI":"10.3389\/fncel.2018.00264","article-title":"Calcium deregulation: novel insights to understand Friedreich's Ataxia pathophysiology","volume":"12","author":"Abeti","year":"2018","journal-title":"Front Cell Neurosci"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"1845","DOI":"10.1002\/acn3.51438","article-title":"Digital endpoints for self-administered home-based functional assessment in pediatric Friedreich's ataxia","volume":"8","author":"Mueller","year":"2021","journal-title":"Ann Clin Transl Neurol"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1042\/NS20180060","article-title":"Role of frataxin protein deficiency and metabolic dysfunction in Friedreich ataxia, an autosomal recessive mitochondrial disease","volume":"2","author":"Clark","year":"2018","journal-title":"Neuronal Signal"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"e0269649","DOI":"10.1371\/journal.pone.0269649","article-title":"A natural history study to track brain and spinal cord changes in individuals with Friedreich's ataxia: TRACK-FA study protocol","volume":"17","author":"Georgiou-Karistianis","year":"2022","journal-title":"PLoS One"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"H2324","DOI":"10.1152\/ajpheart.00990.2020","article-title":"Deficiency of ataxia-telangiectasia mutated kinase modulates functional and biochemical parameters of the heart in response to Western-type diet","volume":"320","author":"Wingard","year":"2021","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1186\/s13023-016-0543-7","article-title":"Ataxia telangiectasia: a review","volume":"11","author":"Rothblum-Oviatt","year":"2016","journal-title":"Orphanet J Rare Dis"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1007\/s13311-018-00696-y","article-title":"Genetics, mechanisms, and therapeutic progress in polyglutamine spinocerebellar ataxias","volume":"16","author":"Buijsen","year":"2019","journal-title":"Neurotherapeutics"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"1972","DOI":"10.1002\/glia.23451","article-title":"Astroglia contribute to the pathogenesis of spinocerebellar ataxia type 1 (SCA1) in a biphasic, stage-of-disease specific manner","volume":"66","author":"Kim","year":"2018","journal-title":"Glia"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1002\/ajmg.a.20428","article-title":"Spinocerebellar ataxia type 2 (SCA2) presenting with ophthalmoplegia and developmental delay in infancy","author":"Moretti","year":"2004","journal-title":"Am J Med Genet A"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1007\/s12035-021-02610-8","article-title":"A novel SCA3 Knock-in mouse model mimics the human SCA3 disease phenotype including neuropathological, behavioral, and transcriptional abnormalities especially in oligodendrocytes","volume":"59","author":"Haas","year":"2022","journal-title":"Mol Neurobiol"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1007\/s00415-018-9076-4","article-title":"Spinocerebellar ataxia: an update","volume":"266","author":"Sullivan","year":"2019","journal-title":"J Neurol"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1093\/brain\/awae330","article-title":"CACNA1A haploinsufficiency leads to reduced synaptic function and increased intrinsic excitability","volume":"148","author":"Hommersom","year":"2024","journal-title":"Brain (London, England: 1878)"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s12993-022-00194-4","article-title":"Effects of the administration of Elovl5-dependent fatty acids on a spino-cerebellar ataxia 38 mouse model","volume":"18","author":"Balbo","year":"2022","journal-title":"Behav Brain Funct"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"954061","DOI":"10.3389\/fresc.2022.954061","article-title":"Personal factors understood through the ecological-enactive model of disability and implications for rehabilitation research","volume":"3","author":"Schwab","year":"2022","journal-title":"Front Rehabil Sci"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"119809","DOI":"10.1016\/j.bbamcr.2024.119809","article-title":"A multiple animal and cellular models approach to study frataxin deficiency in Friedreich Ataxia","volume":"1871","author":"Mosbach","year":"2024","journal-title":"Biochim Biophys Acta, Mol Cell Res"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1016\/j.ymthe.2024.02.033","article-title":"ASOs are an effective treatment for disease-associated oligodendrocyte signatures in premanifest and symptomatic SCA3 mice","volume":"32","author":"Schuster","year":"2024","journal-title":"Mol Ther"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1038\/nature22044","article-title":"Antisense oligonucleotide therapy for spinocerebellar ataxia type 2","volume":"544","author":"Scoles","year":"2017","journal-title":"Nature"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1212\/WNL.0000000000005055","article-title":"Comprehensive systematic review summary: treatment of cerebellar motor dysfunction and ataxia: report of the guideline development, dissemination, and implementation Subcommittee of the American Academy of neurology","volume":"90","author":"Zesiewicz","year":"2018","journal-title":"Neurology"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s11940-019-0549-2","article-title":"The Comprehensive Management of Cerebellar Ataxia in adults","volume":"21","author":"Stephen","year":"2019","journal-title":"Curr Treat Options Neurol"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1038\/nrd4510","article-title":"The re-emergence of natural products for drug discovery in the genomics era","volume":"14","author":"Harvey","year":"2015","journal-title":"Nat Rev Drug Discov"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1002\/mds.29808","article-title":"Calcitriol treatment is safe and increases Frataxin levels in Friedreich Ataxia patients","volume":"39","author":"Alemany-Perna","year":"2024","journal-title":"Mov Disord"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"104458","DOI":"10.1016\/j.phrs.2019.104458","article-title":"Targeting BDNF signaling by natural products: novel synaptic repair therapeutics for neurodegeneration and behavior disorders","volume":"148","author":"Bawari","year":"2019","journal-title":"Pharmacol Res"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"6542","DOI":"10.1093\/hmg\/ddu373","article-title":"Epigallocatechin-3-gallate and tetracycline differently affect ataxin-3 fibrillogenesis and reduce toxicity in spinocerebellar ataxia type 3 model","volume":"23","author":"Bonanomi","year":"2014","journal-title":"Hum Mol Genet"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"2170","DOI":"10.1007\/s00415-016-8244-7","article-title":"Long-term treatment with thiamine as possible medical therapy for Friedreich ataxia","volume":"263","author":"Costantini","year":"2016","journal-title":"J Neurol"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"e177152","DOI":"10.1172\/jci.insight.177152","article-title":"NAD+ precursors prolong survival and improve cardiac phenotypes in a mouse model of Friedreich's Ataxia","volume":"9","author":"Perry","year":"2024","journal-title":"JCI Insight"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1016\/S0140-6736(14)60382-2","article-title":"Epigenetic and neurological effects and safety of high-dose nicotinamide in patients with Friedreich's ataxia: an exploratory, open-label, dose-escalation study","volume":"384","author":"Libri","year":"2014","journal-title":"Lancet"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"234","DOI":"10.12890\/2015_000234","article-title":"Life-threatening adverse reaction after self-initiated, off-label use of high dose nicotinamide for the treatment of Friedreich\u2019s Ataxia. European journal of case reports","volume":"2","author":"Garin","year":"2015","journal-title":"Intern Med"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"e13329","DOI":"10.1111\/acel.13329","article-title":"NAD(+) supplementation prevents STING-induced senescence in ataxia telangiectasia by improving mitophagy","volume":"20","author":"Yang","year":"2021","journal-title":"Aging Cell"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1016\/j.cmet.2016.09.004","article-title":"NAD(+) replenishment improves lifespan and Healthspan in Ataxia telangiectasia models via Mitophagy and DNA repair","volume":"24","author":"Fang","year":"2016","journal-title":"Cell Metab"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1042\/BCJ20200331","article-title":"Calcitriol increases frataxin levels and restores mitochondrial function in cell models of Friedreich Ataxia","volume":"478","author":"Britti","year":"2021","journal-title":"Biochem J"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1111\/nure.12026","article-title":"Bioavailability of vitamin E in humans: an update","volume":"71","author":"Borel","year":"2013","journal-title":"Nutr Rev"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1177\/1535370219890873","article-title":"Effects of tocotrienol supplementation in Friedreich's ataxia: a model of oxidative stress pathology","volume":"245","author":"Bolotta","year":"2020","journal-title":"Exp Biol Med (Maywood)"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"107713","DOI":"10.1016\/j.isci.2023.107713","article-title":"Butyrate prevents visceral adipose tissue inflammation and metabolic alterations in a Friedreich's ataxia mouse model","volume":"26","author":"Turchi","year":"2023","journal-title":"iScience"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"4085","DOI":"10.3390\/molecules25184085","article-title":"Molecular and cellular substrates for the Friedreich Ataxia. Significance of Contactin expression and of antioxidant administration","volume":"25","author":"Bizzoca","year":"2020","journal-title":"Molecules"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"356","DOI":"10.3389\/fncel.2019.00356","article-title":"Nrf2 induction re-establishes a proper neuronal differentiation program in Friedreich's Ataxia neural stem cells","volume":"13","author":"La Rosa","year":"2019","journal-title":"Front Cell Neurosci"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.phrs.2015.05.015","article-title":"Targeting lipid peroxidation and mitochondrial imbalance in Friedreich's ataxia","volume":"99","author":"Abeti","year":"2015","journal-title":"Pharmacol Res"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"101791","DOI":"10.1016\/j.redox.2020.101791","article-title":"The Nrf2 induction prevents ferroptosis in Friedreich's Ataxia","volume":"38","author":"La Rosa","year":"2021","journal-title":"Redox Biol"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"2173","DOI":"10.3390\/ijms18102173","article-title":"Nrf2-inducers counteract neurodegeneration in Frataxin-silenced motor neurons: disclosing new therapeutic targets for Friedreich's Ataxia","volume":"18","author":"Petrillo","year":"2017","journal-title":"Int J Mol Sci"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"5211","DOI":"10.3390\/ijms20205211","article-title":"Targeting NRF2 for the treatment of Friedreich's Ataxia: a comparison among drugs","volume":"20","author":"Petrillo","year":"2019","journal-title":"Int J Mol Sci"},{"key":"ref49","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1016\/j.isci.2019.10.064","article-title":"Single-cell RNA-seq reveals profound alterations in mechanosensitive dorsal root ganglion neurons with vitamin E deficiency","volume":"21","author":"Finno","year":"2019","journal-title":"iScience"},{"key":"ref50","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1093\/jn\/nxz330","article-title":"Synthetic alpha-tocopherol, compared with natural alpha-tocopherol, downregulates myelin genes in cerebella of adolescent Ttpa-null mice","volume":"150","author":"Ranard","year":"2020","journal-title":"J Nutr"},{"key":"ref51","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1159\/000508080","article-title":"First recognized patient with genetic vitamin E deficiency stable after 36 years of controlled supplement therapy","volume":"20","author":"Kohlschutter","year":"2020","journal-title":"Neurodegener Dis"},{"key":"ref52","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1021\/acschemneuro.3c00560","article-title":"Cell-free and in vivo characterization of the inhibitory activity of Lavado cocoa Flavanols on the amyloid protein Ataxin-3: toward new approaches against spinocerebellar Ataxia type 3","volume":"15","author":"Sciandrone","year":"2024","journal-title":"ACS Chem Neurosci"},{"key":"ref53","doi-asserted-by":"publisher","first-page":"11641","DOI":"10.1038\/s41598-017-11839-0","article-title":"Treatment with Caffeic acid and resveratrol alleviates oxidative stress induced neurotoxicity in cell and Drosophila models of spinocerebellar Ataxia Type3","volume":"7","author":"Wu","year":"2017","journal-title":"Sci Rep"},{"key":"ref54","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1007\/s12311-020-01150-6","article-title":"Trehalose in Machado-Joseph disease: safety, tolerability, and efficacy","volume":"19","author":"Zaltzman","year":"2020","journal-title":"Cerebellum"},{"key":"ref55","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1186\/s12967-020-02302-2","article-title":"Trehalose alleviates the phenotype of Machado-Joseph disease mouse models","volume":"18","author":"Santana","year":"2020","journal-title":"J Transl Med"},{"key":"ref56","doi-asserted-by":"publisher","first-page":"893","DOI":"10.3390\/cells12060893","article-title":"Autophagy function and benefits of autophagy induction in models of spinocerebellar Ataxia type 3","volume":"12","author":"Watchon","year":"2023","journal-title":"Cells"},{"key":"ref57","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.neuro.2015.03.009","article-title":"The potential of lactulose and melibiose, two novel trehalase-indigestible and autophagy-inducing disaccharides, for polyQ-mediated neurodegenerative disease treatment","volume":"48","author":"Lee","year":"2015","journal-title":"Neurotoxicology"},{"key":"ref58","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.3390\/nu15061393","article-title":"Dietary Trehalose as a bioactive nutrient","volume":"15","author":"Chen","year":"2023","journal-title":"Nutrients"},{"key":"ref59","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1002\/ana.25059","article-title":"Docosahexaenoic acid is a beneficial replacement treatment for spinocerebellar ataxia 38","volume":"82","author":"Manes","year":"2017","journal-title":"Ann Neurol"},{"key":"ref60","doi-asserted-by":"publisher","first-page":"6095","DOI":"10.1038\/s41598-020-62952-6","article-title":"Long-term voluntary running prevents the onset of symptomatic Friedreich's ataxia in mice","volume":"10","author":"Zhao","year":"2020","journal-title":"Sci Rep"},{"key":"ref61","doi-asserted-by":"publisher","first-page":"5201","DOI":"10.1172\/jci.insight.155201","article-title":"Frataxin deficiency lowers lean mass and triggers the integrated stress response in skeletal muscle","volume":"7","author":"Vasquez-Trincado","year":"2022","journal-title":"JCI Insight"},{"key":"ref62","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1038\/s43856-024-00653-1","article-title":"At-home wearable-based monitoring predicts clinical measures and biological biomarkers of disease severity in Friedreich's Ataxia","volume":"4","author":"Mishra","year":"2024","journal-title":"Commun Med (Lond)"},{"key":"ref63","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1002\/mds.27437","article-title":"Neurorehabilitation therapy in spinocerebellar ataxia type 2: a 24-week, rater-blinded, randomized, controlled trial","volume":"33","author":"Rodriguez-Diaz","year":"2018","journal-title":"Mov Disord"},{"key":"ref64","doi-asserted-by":"publisher","first-page":"168","DOI":"10.4103\/ijoy.ijoy_49_22","article-title":"Integrative approach improves fall risk and postural stability in spinocerebellar Ataxia-2 - a case report","volume":"15","author":"Kulamarva","year":"2022","journal-title":"Int J Yoga"},{"key":"ref65","doi-asserted-by":"publisher","first-page":"8376","DOI":"10.22605\/RRH8376","article-title":"Feasibility and impact of a physical activity and lifestyle program for aboriginal families with Machado-Joseph disease in the top end of Australia","volume":"24","author":"Carr","year":"2024","journal-title":"Rural Remote Health"},{"key":"ref66","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1177\/0269215514539336","article-title":"Training balance with opto-kinetic stimuli in the home: a randomized controlled feasibility study in people with pure cerebellar disease","volume":"29","author":"Bunn","year":"2015","journal-title":"Clin Rehabil"},{"key":"ref67","doi-asserted-by":"publisher","first-page":"4874","DOI":"10.3390\/s21144874","article-title":"Effectiveness of robotic exoskeleton-assisted gait training in spinocerebellar Ataxia: a case report","volume":"21","author":"Kim","year":"2021","journal-title":"Sensors (Basel)"},{"key":"ref68","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1007\/s12311-019-1006-1","article-title":"Effects of physical rehabilitation in patients with spinocerebellar Ataxia type 7","volume":"18","author":"Tercero-Perez","year":"2019","journal-title":"Cerebellum"},{"key":"ref69","doi-asserted-by":"publisher","first-page":"41","DOI":"10.3233\/NRE-210320","article-title":"Effectiveness of functional trunk training on trunk control and upper limb functions in patients with autosomal recessive hereditary ataxia","volume":"51","author":"Yigit","year":"2022","journal-title":"NeuroRehabilitation"},{"key":"ref70","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1007\/s12311-022-01394-4","article-title":"Home aerobic training for cerebellar degenerative diseases: a randomized controlled trial","volume":"22","author":"Barbuto","year":"2023","journal-title":"Cerebellum"},{"key":"ref71","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1177\/0269215520905073","article-title":"Phase I randomized single-blinded controlled study investigating the potential benefit of aerobic exercise in degenerative cerebellar disease","volume":"34","author":"Barbuto","year":"2020","journal-title":"Clin Rehabil"},{"key":"ref72","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1080\/09593985.2022.2037115","article-title":"Effects of therapeutic exercise on disease severity, balance, and functional Independence among individuals with cerebellar ataxia: a systematic review with meta-analysis","volume":"39","author":"Winser","year":"2023","journal-title":"Physiother Theory Pract"},{"key":"ref73","doi-asserted-by":"publisher","first-page":"3512","DOI":"10.3390\/s22093512","article-title":"Preliminary study of Vibrotactile feedback during home-based balance and coordination training in individuals with cerebellar Ataxia","volume":"22","author":"Jabri","year":"2022","journal-title":"Sensors (Basel)"},{"key":"ref74","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1002\/mdc3.14036","article-title":"Effect of a Home-Base Core stability exercises in hereditary Ataxia. A randomized controlled trial. A pilot randomized controlled trial","volume":"11","author":"Cabanas-Valdes","year":"2024","journal-title":"Mov Disord Clin Pract"},{"key":"ref75","doi-asserted-by":"publisher","first-page":"e040230","DOI":"10.1136\/bmjopen-2020-040230","article-title":"Rehabilitation for ataxia study: protocol for a randomised controlled trial of an outpatient and supported home-based physiotherapy programme for people with hereditary cerebellar ataxia","volume":"10","author":"Milne","year":"2020","journal-title":"BMJ Open"},{"key":"ref76","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1002\/ana.27130","article-title":"Goal-directed rehabilitation versus standard Care for Individuals with hereditary cerebellar Ataxia: a multicenter, single-blind, randomized controlled superiority trial","volume":"97","author":"Milne","year":"2024","journal-title":"Ann Neurol"},{"key":"ref77","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1016\/j.apmr.2015.01.021","article-title":"Cycling regimen induces spinal circuitry plasticity and improves leg muscle coordination in individuals with spinocerebellar ataxia","volume":"96","author":"Chang","year":"2015","journal-title":"Arch Phys Med Rehabil"},{"key":"ref78","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2018\/7172686","article-title":"Partial body weight-supported treadmill training in spinocerebellar Ataxia","volume":"2018","author":"de Oliveira","year":"2018","journal-title":"Rehabil Res Pract"},{"key":"ref79","doi-asserted-by":"publisher","first-page":"e14797","DOI":"10.1111\/cns.14797","article-title":"Effects of cerebellar repetitive transcranial magnetic stimulation plus physiotherapy in spinocerebellar ataxias - a randomized clinical trial","volume":"30","author":"Grobe-Einsler","year":"2024","journal-title":"CNS Neurosci Ther"},{"key":"ref80","doi-asserted-by":"publisher","first-page":"3283","DOI":"10.3390\/molecules23123283","article-title":"The potential use of plant natural products and plant extracts with antioxidant properties for the prevention\/treatment of neurodegenerative diseases: in vitro, in vivo and clinical trials","volume":"23","author":"Pohl","year":"2018","journal-title":"Molecules"},{"key":"ref81","doi-asserted-by":"publisher","first-page":"5781","DOI":"10.3390\/ijms24065781","article-title":"Natural products and their derivatives as inhibitors of the DNA repair enzyme Tyrosyl-DNA phosphodiesterase 1","volume":"24","author":"Zakharenko","year":"2023","journal-title":"Int J Mol Sci"},{"key":"ref82","doi-asserted-by":"publisher","first-page":"101712","DOI":"10.1016\/j.jbc.2022.101712","article-title":"The tocopherol transfer protein mediates vitamin E trafficking between cerebellar astrocytes and neurons","volume":"298","author":"Ulatowski","year":"2022","journal-title":"J Biol Chem"},{"key":"ref83","doi-asserted-by":"publisher","first-page":"87","DOI":"10.3389\/fnut.2018.00087","article-title":"The role of polyphenols in human health and food systems: a mini-review","volume":"5","author":"Cory","year":"2018","journal-title":"Front Nutr"},{"key":"ref84","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.foodchem.2016.04.014","article-title":"Vitamins a and E content of commercial infant foods in the UK: a cause for concern?","volume":"210","author":"Loughrill","year":"2016","journal-title":"Food Chem"},{"key":"ref85","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.5551\/jat.RV17056","article-title":"Current diagnosis and Management of Abetalipoproteinemia","volume":"28","author":"Takahashi","year":"2021","journal-title":"J Atheroscler Thromb"},{"key":"ref86","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1002\/ana.25919","article-title":"CAG repeat size influences the progression rate of spinocerebellar Ataxia type 3","volume":"89","author":"Leotti","year":"2021","journal-title":"Ann Neurol"},{"key":"ref87","doi-asserted-by":"publisher","first-page":"e0244311","DOI":"10.1371\/journal.pone.0244311","article-title":"Staying strong toolbox: co-design of a physical activity and lifestyle program for aboriginal families with Machado-Joseph disease in the top end of Australia","volume":"16","author":"Carr","year":"2021","journal-title":"PLoS One"},{"key":"ref88","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1589\/jpts.27.1223","article-title":"Decreasing fall risk in spinocerebellar ataxia","volume":"27","author":"Santos de Oliveira","year":"2015","journal-title":"J Phys Ther Sci."},{"key":"ref89","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1089\/acm.2017.0396","article-title":"Potential benefits and safety of T'ai chi for balance and functional Independence in people with cerebellar Ataxia","volume":"24","author":"Winser","year":"2018","journal-title":"J Altern Complement Med"},{"key":"ref90","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.3390\/jcm11041065","article-title":"Upper body physical rehabilitation for children with Ataxia through IMU-based Exergame","volume":"11","author":"Romano","year":"2022","journal-title":"J Clin Med"},{"key":"ref91","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1007\/s12311-020-01210-x","article-title":"The use of new mobile and gaming technologies for the assessment and rehabilitation of people with Ataxia: a systematic review and meta-analysis","volume":"20","author":"Lacorte","year":"2021","journal-title":"Cerebellum"}],"container-title":["Frontiers in Nutrition"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnut.2025.1548821\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,24]],"date-time":"2025-04-24T05:31:01Z","timestamp":1745472661000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnut.2025.1548821\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,24]]},"references-count":91,"alternative-id":["10.3389\/fnut.2025.1548821"],"URL":"https:\/\/doi.org\/10.3389\/fnut.2025.1548821","relation":{},"ISSN":["2296-861X"],"issn-type":[{"value":"2296-861X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,24]]},"article-number":"1548821"}}